Niki BiosolutionsNIKI
13F holders, Q3 2025 (September 30)3holders −1
0new positions
1sold out
$1.97avg. 13F price*
At the end of Q3 2025, 3 institutions reported holding Niki Biosolutions Inc. (NIKI) in their 13F filings, down 1 from Q2 2025. 0 opened new positions and 1 sold out. The largest holders were Osaic Holdings, Inc. ($11K), Citigroup Inc. ($560) and SBI Securities Co., Ltd. ($14).
- Company
- Niki Biosolutions Inc.
- Filed as
- APTORUM GROUP LIMITED (Q3 2025)
- CUSIP
- G6096M122
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $34K |
All 13F filers, Q2 2025 → Q3 2025: 1 shares bought and 38,167 shares sold, net −38,166 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Osaic Holdings, Inc. | 0.00% | Add +0.0% | 5,501 | $11K |
| Citigroup Inc. | 0.00% | Reduce -72.2% | 277 | $560 |
| SBI Securities Co., Ltd. | 0.00% | No change | 7 | $14 |
"% of holder's portfolio" is NIKI's weight in each manager's 13F, not the share of Niki Biosolutions Inc. the manager owns.